Emergent Biosolutions (EBS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2023 | 12-2022 | 12-2021 | 12-2020 | 12-2019 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 111,700 | 642,600 | 576,300 | 621,500 | 168,000 |
| Receivables | 191,000 | 159,200 | 274,700 | 230,900 | 270,700 |
| Inventories | 328,900 | 350,700 | 350,800 | 307,000 | 222,500 |
| TOTAL | $679,500 | $1,210,400 | $1,272,100 | $1,195,900 | $686,200 |
| Non-Current Assets | |||||
| PPE Net | 382,800 | 817,600 | 800,100 | 644,100 | 542,300 |
| Intangibles | 566,600 | 947,000 | 829,500 | 929,800 | 979,500 |
| Other Non-Current Assets | 194,300 | 191,300 | 57,300 | 113,400 | 119,300 |
| TOTAL | $1,143,700 | $1,955,900 | $1,686,900 | $1,687,300 | $1,641,100 |
| Total Assets | $1,823,200 | $3,166,300 | $2,959,000 | $2,883,200 | $2,327,300 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 413,700 | 957,300 | 31,600 | N/A | 12,900 |
| Accounts payable and accrued liabilities | 112,200 | 103,500 | 128,900 | 136,100 | 94,800 |
| Accrued Expenses | 92,700 | 122,200 | 140,400 | 131,500 | 101,900 |
| Other current liabilities | 32,700 | 45,900 | 72,900 | 116,900 | 6,700 |
| TOTAL | $651,300 | $1,228,900 | $373,800 | $384,500 | $216,300 |
| Non-Current Liabilities | |||||
| Long Term Debt | 446,500 | 448,500 | 809,400 | 841,000 | 798,400 |
| Other Non-Current Liabilities | 28,900 | 41,500 | 61,900 | 157,500 | 74,600 |
| TOTAL | $522,600 | $549,700 | $966,200 | $1,051,700 | $1,022,500 |
| Total Liabilities | $1,173,900 | $1,778,600 | $1,340,000 | $1,436,200 | $1,238,800 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 52,203 | 50,140 | 50,501 | 53,300 | 52,000 |
| Common Shares | 100 | 100 | 100 | 100 | 100 |
| Retained earnings | -21,800 | 738,700 | 957,800 | 726,900 | 421,800 |
| Other shareholders' equity | -5,400 | 3,400 | -16,300 | -24,900 | -9,500 |
| TOTAL | $649,300 | $1,387,700 | $1,619,000 | $1,447,000 | $1,088,500 |
| Total Liabilities And Equity | $1,823,200 | $3,166,300 | $2,959,000 | $2,883,200 | $2,327,300 |